First Tracks Biotherapeutics, Inc. Stock Price

NasdaqGS:TRAX Community·US$631.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

TRAX Share Price Performance

US$18.16

-0.84 (-4.42%)

US$18.16

-0.84 (-4.42%)

US$18.16

Sun, 26 Apr 26

Share Pricen/a

TRAX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks

0 Rewards

View Full Analysis

First Tracks Biotherapeutics, Inc. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -4.78
: 0%
: 0%
: 0%

View Full Analysis

About TRAX

Founded: 2025
Employees: 104
CEO: Daniel Faga
Website: n/a

First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.